GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Progenics Pharmaceuticals Inc. (PGNX) [hlAlert]

Progenics Pharmaceuticals, Inc. is a biopharmaceutical company focusing on the development & commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Principal programs are directed toward symptom management and supportive care
and the treatment of HIV infection and cancer. The Company has four product candidates in clinical development and several others in preclinical development. The Company in collaboration with Wyeth, is developing methylnaltrexone for the treatment of opioid-induced side effects, including constipation and post-operative ileus. In the area of HIV infection, the Company is developing the viral-entry inhibitor PRO one hundred forty, a humanized monoclonal antibody targeting the HIV coreceptor CCR5. In addition, the Company is conducting research on ProVax, a novel prophylactic HIV vaccine.
( Total: 12 Current Stock Recommendations )
Progenics Pharmaceuticals Inc.   (12)
Sell Hold 42% Buy 50%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
11/8/2007  
Buy
  
3/12/2008  
Hold
  
4/25/2008  
Hold
  
6/6/2008  
Buy
  
7/2/2008  
Sell
  
3/12/2009  
Hold
  
3/16/2009  
None
  
5/12/2009  
Buy
  
2/10/2011  
Buy
  
8/30/2012  
Hold
  
11/8/2012  
Hold
  
2/3/2014  
Buy
  
8/6/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy